JP2022543112A5 - - Google Patents
Info
- Publication number
- JP2022543112A5 JP2022543112A5 JP2022506729A JP2022506729A JP2022543112A5 JP 2022543112 A5 JP2022543112 A5 JP 2022543112A5 JP 2022506729 A JP2022506729 A JP 2022506729A JP 2022506729 A JP2022506729 A JP 2022506729A JP 2022543112 A5 JP2022543112 A5 JP 2022543112A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- gene
- sequence encoding
- group
- dux4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962881840P | 2019-08-01 | 2019-08-01 | |
| US62/881,840 | 2019-08-01 | ||
| PCT/US2020/044635 WO2021022223A1 (en) | 2019-08-01 | 2020-07-31 | Dux4 expressing cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543112A JP2022543112A (ja) | 2022-10-07 |
| JP2022543112A5 true JP2022543112A5 (cg-RX-API-DMAC7.html) | 2023-08-08 |
Family
ID=72088403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506729A Pending JP2022543112A (ja) | 2019-08-01 | 2020-07-31 | Dux4発現細胞およびそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220267732A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4007596A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022543112A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021022223A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11162079B2 (en) | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
| US11459372B2 (en) | 2020-11-30 | 2022-10-04 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| EP4271798A1 (en) | 2020-12-30 | 2023-11-08 | CRISPR Therapeutics AG | Compositions and methods for differentiating stem cells into nk cells |
| US11965022B2 (en) | 2020-12-31 | 2024-04-23 | Sana Biotechnology, Inc. | Methods and compositions for modulating CAR-T activity |
| WO2022251443A1 (en) * | 2021-05-26 | 2022-12-01 | FUJIFILM Cellular Dynamics, Inc. | Methods to prevent rapid silencing of genes in pluripotent stem cells |
| WO2022269393A1 (en) * | 2021-06-23 | 2022-12-29 | Crispr Therapeutics Ag | Engineered cells with improved protection from natural killer cell killing |
| CA3225283A1 (en) | 2021-07-14 | 2023-01-19 | Sonja SCHREPFER | Altered expression of y chromosome-linked antigens in hypoimmunogenic cells |
| US20260053851A1 (en) | 2021-08-11 | 2026-02-26 | Sana Biotechnology, Inc. | Inducible systems for altering gene expression in hypoimmunogenic cells |
| AU2022325231A1 (en) * | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions |
| US20250339531A1 (en) * | 2021-11-12 | 2025-11-06 | Fred Hutchinson Cancer Center | Dux4 polypeptides and nucleic acids for treating inflammatory and autoimmune conditions |
| WO2023122337A1 (en) | 2021-12-23 | 2023-06-29 | Sana Biotechnology, Inc. | Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods |
| EP4479084A1 (en) | 2022-02-14 | 2024-12-25 | Sana Biotechnology, Inc. | Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells |
| IL318041A (en) * | 2022-07-01 | 2025-02-01 | Janssen Biotech Inc | Materials and methods for bioengineered iPSC populations |
| WO2024012420A1 (zh) * | 2022-07-11 | 2024-01-18 | 士泽生物医药(苏州)有限公司 | 一种表达faslg的通用型细胞及其制备方法 |
| CN118207166A (zh) * | 2022-12-16 | 2024-06-18 | 士泽生物医药(苏州)有限公司 | 一种通用型细胞及其制备方法 |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
| WO2025230941A1 (en) | 2024-04-30 | 2025-11-06 | Satellite Biosciences, Inc. | Hypoimmunogenic cell mixtures and methods of use thereof |
| WO2025230947A1 (en) | 2024-04-30 | 2025-11-06 | Satellite Biosciences, Inc. | Engineered hepatocytes for secreting polypeptides |
| GB202415025D0 (en) * | 2024-10-11 | 2024-11-27 | Ospedale San Raffaele Srl | Cell |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422251A (en) | 1986-11-26 | 1995-06-06 | Princeton University | Triple-stranded nucleic acids |
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6503717B2 (en) | 1999-12-06 | 2003-01-07 | Sangamo Biosciences, Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| US7070934B2 (en) | 1999-01-12 | 2006-07-04 | Sangamo Biosciences, Inc. | Ligand-controlled regulation of endogenous gene expression |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US7030215B2 (en) | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
| AU2001250774B2 (en) | 2000-02-08 | 2005-01-27 | Sangamo Biosciences, Inc. | Cells expressing zinc finger proteins for drug discovery |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| US7262054B2 (en) | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
| US7361635B2 (en) | 2002-08-29 | 2008-04-22 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| ATE418346T1 (de) | 2004-04-08 | 2009-01-15 | Sangamo Biosciences Inc | Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen |
| US7253273B2 (en) | 2004-04-08 | 2007-08-07 | Sangamo Biosciences, Inc. | Treatment of neuropathic pain with zinc finger proteins |
| DK3246403T3 (da) | 2005-10-18 | 2020-10-26 | Prec Biosciences | Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet |
| AU2011256838B2 (en) | 2010-05-17 | 2014-10-09 | Sangamo Therapeutics, Inc. | Novel DNA-binding proteins and uses thereof |
| US9089520B2 (en) | 2010-05-21 | 2015-07-28 | Baylor College Of Medicine | Methods for inducing selective apoptosis |
| US20140115726A1 (en) | 2011-04-05 | 2014-04-24 | Cellectis | New tale-protein scaffolds and uses thereof |
| CA2865011C (en) | 2012-02-29 | 2021-06-15 | Sangamo Biosciences, Inc. | Methods and compositions for treating huntington's disease |
| EP3294342A4 (en) | 2015-05-08 | 2018-11-07 | President and Fellows of Harvard College | Universal donor stem cells and related methods |
| US20200087629A1 (en) * | 2016-10-19 | 2020-03-19 | Fred Hutchinson Cancer Research Center | Compositions and methods for reprogramming cells and for somatic cell nuclear transfer using duxc expression |
| KR20240095477A (ko) * | 2017-01-13 | 2024-06-25 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 면역조작된 만능 세포 |
| EP3601528A4 (en) | 2017-03-20 | 2021-05-05 | Washington University | Cells and methods of uses and making the same |
| WO2020028134A1 (en) * | 2018-07-30 | 2020-02-06 | Fred Hutchinson Cancer Research Center | Methods and compositions for treating cancer |
-
2020
- 2020-07-31 EP EP20757473.2A patent/EP4007596A1/en active Pending
- 2020-07-31 US US17/632,026 patent/US20220267732A1/en active Pending
- 2020-07-31 JP JP2022506729A patent/JP2022543112A/ja active Pending
- 2020-07-31 WO PCT/US2020/044635 patent/WO2021022223A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546317A5 (cg-RX-API-DMAC7.html) | ||
| Gornalusse et al. | HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells | |
| Wu et al. | Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies | |
| JP6516740B2 (ja) | 幹細胞及びキメラ抗原受容体を介した抗腫瘍性t細胞免疫の改変 | |
| JP6346266B2 (ja) | 操作されたジンクフィンガータンパク質ヌクレアーゼを使用するt細胞受容体遺伝子の標的化された破壊 | |
| US9228007B1 (en) | Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells | |
| CN115298314A (zh) | 基因表达调控的安全开关 | |
| US20190161530A1 (en) | Chimeric antigen receptor t cell compositions | |
| US20230272429A1 (en) | Modification of blood type antigens | |
| Goffinet et al. | Efficient nonviral gene delivery into primary lymphocytes from rats and mice | |
| JP2022512674A (ja) | 人工トランス活性化因子による選択 | |
| JP2025061188A (ja) | キメラサイトカイン受容体 | |
| Su et al. | Genome-edited allogeneic CAR-T cells: the next generation of cancer immunotherapies | |
| KR20210116531A (ko) | 영양 장애형 표피 수포증 치료약 | |
| Zhang et al. | Adoptive T cell therapy following haploidentical hematopoietic stem cell transplantation | |
| WO2022018884A1 (ja) | 栄養障害型表皮水疱症の治療薬 | |
| Amrolia et al. | Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation | |
| US11903969B2 (en) | Genome editing of graft-derived T-cells for post-transplant immunotherapy | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| JP7807756B2 (ja) | 所望の特異性を有するエフェクター細胞の製造方法 | |
| KR102906951B1 (ko) | 내인성 항원 제시 기전을 이용한 저면역원성 줄기세포 및 이의 제조 방법 | |
| Moen | Transfection of Stem Cells and Gene Therapy | |
| EA053040B1 (ru) | Универсальная клетка и способ ее получения | |
| Wang et al. | 187. Comprehensive Integration Site Analysis of One New Gene Therapy Vector AAV-rDNA | |
| WO2025181283A1 (en) | Cell |